Professional Development

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

A practical guide to baseline testing, follow-up laboratory monitoring, and managing abnormalities in patients receiving oral JAK inhibitors.

Learn how private equity rollups reshape dermatology—EBITDA deals, MSOs, and the real tradeoffs for owners, PAs, and new grads.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Updated Allergan Partner Privileges offers simplified savings, greater benefits transparency, portfolio-level rewards, and a new BOTOX Cosmetic growth rebate.

Victoria Garcia-Albea, NP, discussed the learning curve dermatology NP fellows experience and the need for greater dermatology education for APPs.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Eileen Cheever, PA, discussed how understanding immunologic pathways can strengthen patient counseling and treatment confidence in dermatology.

Kimberly Madison, DNP, and Jade Trevino, BSN, RN, discussed nurse-led triage, task shifting, and AI-supported care models for expanding dermatology access in a recent Dermatology Times interview.

In this edition of The Practice Playbook, learn incident-to rules, Mohs coding limits, NPI liability, and how audits and whistleblowers trigger FCA cases.

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Justin Love, PA-C, explains how multidisciplinary care and earlier targeted therapy can improve chronic inflammatory skin disease outcomes.

At Elevate-Derm, Justin Love, PA-C, explains why planning is essential for successful and meaningful patient discussions.

Systematic review highlights AI-supported triage, nursing education, and workforce strategies for underserved communities

Every week, we cut through the noise to bring clinicians the trial results, approvals, and emerging therapies that are actually moving the needle.

Career decisions in dermatology are too often driven by emotion rather than data, according to a new practice management column examining common pitfalls in contract evaluation and compensation negotiations.

Two clinic cases illustrate why dermatologic providers must apply broad general medicine training in every encounter.

In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.

Valerie Stern, DMSc, MPAS, PA-C, argues that dermatology conferences offer APPs something CME alone can't — a community that understands the specific professional pressures of the role.

From case reports to conference presentations, Stern outlines a practical path APPs can follow to build a profile beyond their day-to-day clinical role.

In the Chair puts you in the hot spot, challenging you to navigate complex, real-world cases.

As one of California's first derm PAs, Stern discusses the mentorship-driven private practice model that launched her career and its near-disappearance today.